Viscofan (VIS)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 54.30 |
|---|---|
| 52-week range | 51.20 – 62.30 |
| Return, 1 month / 3 months | −1.3% / −3.6% |
| Return, 1 year / 3 years | +6.1% / +15.0% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 15.2% |
| Worst drawdown (1 year) | -12.6% |
| Average daily value traded | 3.98M EUR |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Viscofan makes casings for sausages and other meat products, using cellulose, collagen and plastic materials. Its customers are food manufacturers and meat processors who use these casings to shape, stuff and package their products. The company also produces films and packaging for food applications. It is based in Navarra, Spain, and serves food producers in many countries around the world.
The shares are listed on the Madrid Exchange in Spain under the code VIS, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Viscofan (VIS) trades on the Madrid Exchange in Spain. It last closed at EUR 54.30 on 22 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 80 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.1% and over the last three months it fell 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.9% | ||
| From 52-week high | -12.6% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.6% | ||
| 6-month return | -5.3% | ||
| 12-month return, skipping the last month | 7.5% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 15.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.6% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 3.98M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 83 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | −1.3% |
| 3 months | −3.6% |
| 6 months | −5.3% |
| 1 year | +6.1% |
| 3 years | +15.0% |
| 5 years | +16.6% |
Signals
| 50-day / 200-day average | 55.12 / 56.50 |
|---|---|
| Golden / death cross (60 days) | Death, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jun 2026 | EUR 1.4572 |
| 20 Nov 2025 | EUR 1.2012 |
| 15 May 2025 | EUR 1.3673 |
| 22 Nov 2024 | EUR 1.1640 |
| 28 May 2024 | EUR 1.2928 |
| 18 Dec 2023 | EUR 1.1340 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.